Background Various vaccines have been developed and distributed worldwide to control and cope with COVID-19 disease. To ensure vaccines benefit the global community, the …
K Maeda, M Amano, Y Uemura, K Tsuchiya… - Scientific Reports, 2021 - nature.com
While mRNA vaccines against SARS-CoV-2 are exceedingly effective in preventing symptomatic infection, their immune response features remain to be clarified. In the present …
The recent SARS-CoV-2 outbreak has been declared a global health emergency. It will take years to vaccinate the whole population to protect them from this deadly virus, hence the …
M Amano, S Otsu, Y Uemura, Y Ichikawa… - Scientific Reports, 2023 - nature.com
Abstract SARS-CoV-2-BA. 4/5-adapted-bivalent-BNT162b2-vaccine (bvBNT), developed in response to the recent emergence of immune-evasive Omicron-variants, has been given to …
M Amano, S Otsu, K Maeda, Y Uemura, Y Shimizu… - Scientific Reports, 2022 - nature.com
In the present prospective study, 225 individuals in Kumamoto General Hospital, Japan, who received two-doses of BNT162b2 vaccine were enrolled/followed up over 150 days and …
WF Elkhatib, SS Abdelkareem, WS Khalaf, MI Shahin… - Virology journal, 2022 - Springer
The rise of the highly lethal severe acute respiratory syndrome-2 (SARS-2) as corona virus 2019 (COVID-19) reminded us of the history of other pandemics that happened in the last …
R Dal-Ré, AL Caplan - Clinical …, 2021 - clinicalmicrobiologyandinfection …
Is it ethical to have a placebo arm in any COVID-19 vaccine trial at this point in time in high- income countries like the USA and those in Europe, where all adults have access to …
Building the safety of COVID-19 vaccines is a continuous process throughout the vaccine life cycle; It starts early at the clinical trial in different phases and continues to post-marketing to …
C Castellano-Tejedor, M Torres-Serrano… - International journal of …, 2021 - mdpi.com
COVID-19 vaccines are essential to limit and eliminate the infectious disease. This research aims to identify strong vaccination resistance profiles and/or hesitation considering health …